MA31226B1 - Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide. - Google Patents

Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide.

Info

Publication number
MA31226B1
MA31226B1 MA32157A MA32157A MA31226B1 MA 31226 B1 MA31226 B1 MA 31226B1 MA 32157 A MA32157 A MA 32157A MA 32157 A MA32157 A MA 32157A MA 31226 B1 MA31226 B1 MA 31226B1
Authority
MA
Morocco
Prior art keywords
stability
determining
methyleneamines
organic
amine oxidase
Prior art date
Application number
MA32157A
Other languages
Arabic (ar)
English (en)
Inventor
Adedayo Adedoyin
Michael R Angelastro
Julie Ann Bick
Jennifer Cairns
Yongqing Huang
Guyan Liang
Heng-Keang Lim
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MA31226B1 publication Critical patent/MA31226B1/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE DES PROCÉDÉS PERMETTANT DE DÉTERMINER LA STABILITÉ DE LA MÉTHYLÈNEAMINE, DE COMPOSÉS SIMILAIRES À LA MÉTHYLÈNEAMINE OU DE COMPOSÉS CONTENANT UN GROUPE MÉTHYLÈNEAMINE EN PRÉSENCE D'UNE AMINE OXYDASE SENSIBLE AU SEMICARBAZIDE (SSAO) OU D'UN ÉCHANTILLON RENFERMANT UNE ACTIVITÉ SSAO. LES PROCÉDÉS DÉCRITS PEUVENT ÊTRE CONFIGURÉS DANS UN FORMAT DE DOSAGE POUR DES APPLICATIONS DE CRIBLAGE À HAUT DÉBIT.
MA32157A 2007-01-10 2009-08-06 Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide. MA31226B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88426307P 2007-01-10 2007-01-10
PCT/US2008/050456 WO2008086325A1 (fr) 2007-01-10 2008-01-08 Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide

Publications (1)

Publication Number Publication Date
MA31226B1 true MA31226B1 (fr) 2010-03-01

Family

ID=39361382

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32157A MA31226B1 (fr) 2007-01-10 2009-08-06 Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide.

Country Status (29)

Country Link
US (3) US20100028895A1 (fr)
EP (1) EP2121964A1 (fr)
JP (2) JP2010515461A (fr)
KR (1) KR20090107533A (fr)
CN (1) CN101578375B (fr)
AR (1) AR064776A1 (fr)
AU (1) AU2008204923A1 (fr)
BR (1) BRPI0806321A2 (fr)
CA (1) CA2674704A1 (fr)
CR (1) CR10862A (fr)
DO (1) DOP2009000175A (fr)
EC (1) ECSP099507A (fr)
GT (1) GT200900199A (fr)
HN (1) HN2009001289A (fr)
IL (1) IL199707A0 (fr)
MA (1) MA31226B1 (fr)
MX (1) MX2009005962A (fr)
MY (1) MY152893A (fr)
NI (1) NI200900132A (fr)
NO (1) NO20092816L (fr)
NZ (1) NZ578079A (fr)
RU (1) RU2009130380A (fr)
SG (1) SG177920A1 (fr)
SV (1) SV2009003327A (fr)
TN (1) TN2009000232A1 (fr)
TW (1) TW200907065A (fr)
UA (1) UA103300C2 (fr)
WO (1) WO2008086325A1 (fr)
ZA (1) ZA200903897B (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100533911B1 (ko) 1997-05-23 2005-12-06 바이오티에 세라피스 코포레이션 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
JP4499918B2 (ja) * 1998-03-27 2010-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高スループット・スクリーニング用の小型化マイクロタイタ・プレート
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
EP1362120A1 (fr) 2001-02-23 2003-11-19 Biovitrum Ab Procede de purification de ssao soluble

Also Published As

Publication number Publication date
MY152893A (en) 2014-11-28
MX2009005962A (es) 2009-06-15
AU2008204923A1 (en) 2008-07-17
HK1137784A1 (en) 2010-08-06
TW200907065A (en) 2009-02-16
EP2121964A1 (fr) 2009-11-25
BRPI0806321A2 (pt) 2011-09-06
KR20090107533A (ko) 2009-10-13
US20130071870A1 (en) 2013-03-21
TN2009000232A1 (en) 2010-10-18
GT200900199A (es) 2010-04-13
NO20092816L (no) 2009-08-10
CR10862A (es) 2009-08-12
WO2008086325A1 (fr) 2008-07-17
SV2009003327A (es) 2010-02-05
RU2009130380A (ru) 2011-02-20
JP2014204727A (ja) 2014-10-30
WO2008086325A8 (fr) 2009-07-16
NI200900132A (es) 2010-03-01
AR064776A1 (es) 2009-04-22
US20100028895A1 (en) 2010-02-04
US8883410B2 (en) 2014-11-11
JP2010515461A (ja) 2010-05-13
HN2009001289A (es) 2013-02-11
UA103300C2 (ru) 2013-10-10
NZ578079A (en) 2013-02-22
IL199707A0 (en) 2010-04-15
US20140363836A1 (en) 2014-12-11
DOP2009000175A (es) 2009-07-31
CN101578375B (zh) 2012-11-07
CN101578375A (zh) 2009-11-11
SG177920A1 (en) 2012-02-28
ZA200903897B (en) 2010-04-28
ECSP099507A (es) 2009-08-28
CA2674704A1 (fr) 2008-07-17

Similar Documents

Publication Publication Date Title
Delgado et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia
WO2008034110A9 (fr) Utilisation d'enzymes mutantes de type taq polymérase pour l'amplification d'adn en présence d'inhibiteurs de pcr
WO2007106802A3 (fr) Procédé d'amplification linéaire d'adn modifié au bisulfite
WO2018222585A8 (fr) Détection et quantification de molécules uniques d'acides nucléiques à spécificité de base unique
MX2010000031A (es) Deteccion mejorada de microorganismos.
EP2166110A4 (fr) PROCÉDÉ DE CRIBLAGE EMPLOYANT UN NOUVEAU SUBSTRAT EphA4 POUR LA GAMMA-SECRÉTASE
EA200701742A1 (ru) Способы получения сиропа
NO20063939L (no) Oksiderbare spesier som en intern referanse for biosensorer og fremgangsmate for anvendelse
Komarova et al. Development of a novel enzymatic biosensor based on an ion-selective field effect transistor for the detection of explosives
EP1179091B2 (fr) Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
WO2009064006A1 (fr) PROCÉDÉ DE CRIBLAGE UTILISANT UN NOUVEAU SUBSTRAT EphA7 POUR LA γ-SECRÉTASE
MA31226B1 (fr) Procédé permettant de déterminer la stabilité des méthylèneamines organiques en présence d'une amine oxydase sensible au semicarbazide.
Castanheira et al. A novel microfluidic system for the sensitive and cost-effective detection of okadaic acid in mussels
Tiwari et al. Assessment of genetic diversity and distribution of endophytic fungal communities of Alternaria solani isolates associated with the dominant Karanja plants in Sanganer Region of Rajasthan
EP0549776B2 (fr) Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes
Kostyu et al. Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays
ATE368222T1 (de) Entglykosilierte enzymen für konjugaten
Hansen et al. The potential of 3rd‐generation nanopore sequencing for B‐cell clonotyping in lymphoproliferative disorders
WO1997046700A1 (fr) Sondes nucleotidiques et procede pour determiner le typage hla dqb1
AR058185A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
GB2452208A (en) Electrochemical detection of amine compounds
Zhu et al. Isolation and characterization of 100 SNP markers in lined seahorse (Hippocampus erectus) using RAD sequencing
CA2998057A1 (fr) Procede et dispositif pour le genotypage de snp
EP1732880A4 (fr) Analyses visant a detecter la presence d'amphetamine et de methamphetamine
WO2007044864A3 (fr) Detection de signaux d'acides nucleiques cibles